Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B/2A, Open-label, Non-randomized, Multi-arm Study of TL32711 in Combination With Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors

NCT01188499 is registered in ClinicalTrials.gov with TetraLogic Pharmaceuticals as lead sponsor.

NCT NCT01188499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01188499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B/2A, Open-label, Non-randomized, Multi-arm Study of TL32711 in Combination With Chemotherapy in Subjects With Advanced or Metastatic Solid Tumors
Lead sponsor
TetraLogic Pharmaceuticals
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2010
Completion date
March 31, 2014
Enrollment
176 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cancer